Zobrazeno 1 - 10
of 14
pro vyhledávání: '"José Manuel Rodríguez Heredia"'
Publikováno v:
Educación Médica, Vol 7, Iss 2, Pp 53-53 (2004)
Externí odkaz:
https://doaj.org/article/def87370a41c4a399b821064344958ca
Autor:
Cristina Fernández-Carballido, Vega Jovaní, Emma Beltrán Catalán, Manuel José Moreno-Ramos, Jesús Sanz Sanz, Adela Gallego, M. Luz García Vivar, José Manuel Rodríguez-Heredia, Cristina Sanabra, Carlos Sastré
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundTo evaluate gender differences in disease activity and health status (HS) in patients with radiographic axial spondyloarthritis (r-axSpA)/ankylosing spondylitis (AS).MethodsAncillary analysis of the MIDAS study, an observational, non-interv
Externí odkaz:
https://doaj.org/article/a56e69b0dc284405a1e2067791965794
Publikováno v:
Educación Médica, Vol 7, Iss 2, Pp 53-53
Externí odkaz:
https://doaj.org/article/a55a03c3ef824eb79f38afc9cbcbc7ae
Autor:
Alina Boteanu, Leticia Leon, Silvia Pérez Esteban, Elena Rabadán Rubio, Marina Pavía Pascual, Gema Bonilla, Carmen Bonilla González-Laganá, Antia García Fernandez, Sheila Recuero Diaz, Lucia Ruiz Gutierrez, José Javier Sanmartín Martínez, Natalia de la Torre-Rubio, Laura Nuño, Olga Sánchez Pernaute, Iván del Bosque, Leticia Lojo Oliveira, José Manuel Rodríguez Heredia, Daniel Clemente, Lydia Abasolo, Javier Bachiller-Corral
Publikováno v:
Modern rheumatology.
Objectives The aim of this study is to evaluate risk factors for severe coronavirus disease 2019 (COVID-19) in patients with immune-mediated rheumatic diseases, stratified by systemic autoimmune conditions and chronic inflammatory arthritis. Methods
Autor:
Susana Romero-Yuste, Paloma Vela-Casasempere, Jaime Calvo-Alén, Jose Luis Baquero, Loreto Carmona, Santiago Muñoz-Fernández, Javier Narváez, Teresa Otón, José Manuel Rodríguez-heredia, Sara Lujan, Alejandro Escudero-Contreras
Publikováno v:
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Universidad Europea (UEM)
Objectives: To explore current evidence on the management of poor prognostic factors in rheumatoid arthritis (RA) and to investigate whether this evidence is taken into account by clinicians when deciding on treatment in daily clinical practice. Meth
Autor:
Ana Royo García, Jaime Calvo-Alén, Teresa Oton-Sanchez, Sara Lujan Valdés, Javier Narváez, Paloma Vela, José Manuel Rodríguez Heredia, Susana Romero Yuste, Jose Luis Baquero, Loreto Carmona, Alejandro Escudero, Santiago Muñoz-Fernández
Publikováno v:
Rheumatology International. 38:2289-2296
The aim of the study is to benchmark the use and attributed importance of well-established prognostic factors in rheumatoid arthritis (RA) in daily clinical practice, and to contrast the use of factors with their ability to predict outcome. Medline w
Autor:
Santiago Muñoz-Fernández, Jaime Calvo Alén, José Manuel Rodríguez Heredia, José Javier Pérez Venegas, Hèctor Corominas, Nagore Fernández-Llanio Comella, Eugenio Chamizo Carmona, Susana Romero Yuste, María Sagrario Bustabad Reyes, Virginia Ruiz-Esquide Torino, Manuel Castaño Sanchez, María Cristina Hidalgo Calleja
Publikováno v:
Reumatología Clínica (English Edition). 14:90-96
Objective To date, between 17% and 35% of patients with rheumatoid arthritis (RA) do not respond as expected to the initial biological therapy. The objective of this project is to recognize and weigh the attributes of biologic DMARD (bDMARD) to ident
Autor:
Alejandro Escudero Contreras, Susana Romero-Yuste, José Manuel Rodríguez-heredia, Paloma Vela Casasempere, Juan J. Sancho Jiménez, Jaime Calvo, Santiago Muñoz Fernández, Sara Lujan Valdés, Jose Luis Baquero, Loreto Carmona, J.A. Narváez
Publikováno v:
Abstracts Accepted for Publication.
Background Currently, patients with rheumatoid arthritis (RA) have a wide range of treatments available to achieve a good control of the disease and avoid progression. However, some patients, especially those with poor prognostic factors, need to swi
Autor:
H. Corominas, Jaime Calvo Alén, José Javier Pérez Venegas, Manuel Castaño Sanchez, Eugenio Chamizo Carmona, Santiago Muñoz-Fernández, María Cristina Hidalgo Calleja, Virginia Ruiz-Esquide Torino, María Sagrario Bustabad Reyes, Susana Romero Yuste, Nagore Fernández-Llanio Comella, José Manuel Rodríguez Heredia
Existen pacientes con artritis reumatoide (AR) que no responden de la forma deseada a la terapia biológica. Nuestro objetivo fue reconocer los atributos del FAME biológico (FAMEb) que podrían identificar al más adecuado en las primeras líneas de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a90c914d514bc690ea9e6d4d59c5d88
https://hdl.handle.net/11268/6173
https://hdl.handle.net/11268/6173
Autor:
Oscar Illera, Alejandro Balsa, José Luis Andreu, J. Rivera, Santos Castañeda, Esther Toledano, Virginia Villaverde, Loreto Carmona, Ana M. Ortiz, Juan Angel Jover, Javier Orte, José Manuel Rodríguez Heredia, Isabel Mateo, Isidoro González-Álvaro, Estíbaliz Loza, Cristina Lajas, Juan Antonio Martínez-López, Fredeswinda Romero
Publikováno v:
Rheumatology International. 35:445-458
The objective of the study was to develop evidence-based and practical recommendations for the detection and management of comorbidity in patients with rheumatoid arthritis (RA) in daily practice. We used a modified RAND/UCLA methodology and systemat